retatrutide phase 2 results weight loss Safety, Side Effects & Provider Use Triumph-1 Trial Results for Retatrutide

And some of it is valid

63 Given known disparities in hypertension prevalence, control rates, and treatment response across racial groups, 64 further research is needed to assess whether GLP-1 RAs provide comparable benefits across diverse populations

Concerns over more severe adverse effects, including pancreatitis and possible thyroid tumors, may further deter both patients and healthcare providers from utilizing these medications

Thank you Phyllis (pre-op) for being so wonderful and informative

There are a smattering of studies here and there, small studies that look at one type of substance usefor example, alcoholbut there really is not a single human study that comprehensively evaluates two things: 1) the risk of new onset substance use disorders across all major substances, and 2) harm reduction, or the question of do these drugs really reduce the risk of drug overdoses, drug deaths, drug-related hospitalizations, emergency room visits, and suicides, says Al-Aly